Evidence map›Paper›PMID 15987907›Full record

ArticleProtein science : a publication of the Protein Society2005

Boundaries and physical characterization of a new domain shared between mammalian 53BP1 and yeast Rad9 checkpoint proteins.

Béatrice Alpha-Bazin, Alain Lorphelin, Nathalie Nozerand, Gaëlle Charier, Charles Marchetti, Frédéric Bérenguer, Joël Couprie, Bernard Gilquin, Sophie Zinn-Justin, Eric Quéméneur

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Protein science : a publication of the Protein Society, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. TPI and GAPDH Interact with Rad9, Linking Glycolytic Enzymes to Cancer.International journal of molecular sciences · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Béatrice Alpha-BazinService de Biochimie Post-Génomique et Toxicologie Nucléaire, Direction des Sciences du Vivant (DSV)--Département d'Ingénierie et d'Etudes des Protéines (DIEP), Commissariat à l'Energie Atomique (CEA-VALRHO), Bagnols-sur-Céze, France.
Alain Lorphelin
Nathalie Nozerand
Gaëlle Charier
Charles Marchetti
Frédéric Bérenguer
Joël Couprie
Bernard Gilquin
Sophie Zinn-Justin
Eric Quéméneur
Commissariat à l'Énergie Atomique et aux Énergies Alternatives · FRCEA Paris-Saclay · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Eukaryotic cells have evolved DNA damage checkpoints in response to genome damage. They delay the cell cycle and activate repair mechanisms. The kinases at the heart of these pathways and the accessory proteins, which localize to DNA lesions and regulate kinase activation, are conserved from yeast to mammals. For Saccharomyces cerevisiae Rad9, a key adaptor protein in DNA damage checkpoint pathways, no clear human ortholog has yet been described in mammals. Rad9, however, shares localized homology with both human BRCA1 and 53BP1 since they all contain tandem C-terminal BRCT (BRCA1 C-terminal) motifs. 53BP1 is also a key mediator in DNA damage signaling required for cell cycle arrest, which has just been reported to possess a tandem Tudor repeat upstream of the BRCT motifs. Here we show that the major globular domain upstream of yeast Rad9 BRCT domains is structurally extremely similar to the Tudor domains recently resolved for 53BP1 and SMN. By expressing several fragments encompassing the Tudor-related motif and characterizing them using various physical methods, we isolated the independently folded unit for yeast Rad9. As in 53BP1, the domain corresponds to the SMN Tudor motif plus the contiguous HCA predicted structure region at the C terminus. These domains may help to further elucidate the structural and functional features of these two proteins and improve knowledge of the proteins involved in DNA damage.

Indexed as

DNA DamageAmino Acid SequenceBRCA1 ProteinCell Cycle ProteinsHumansIntracellular Signaling Peptides and ProteinsMolecular Sequence DataNuclear ProteinsPhosphoproteinsProtein BindingProtein Structure, TertiarySaccharomyces cerevisiaeSequence Homology, Amino AcidTumor Suppressor p53-Binding Protein 1Tumor Suppressor Protein p53BRCA1 ProteinCell Cycle ProteinsIntracellular Signaling Peptides and ProteinsNuclear ProteinsPhosphoproteinsrad9 proteinTP53BP1 protein, humanTumor Suppressor p53-Binding Protein 1Tumor Suppressor Protein p53

Identifiers

PMID15987907
PMCPMC2253359
OpenAlexW2075317176

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.